TransMedics (TMDX) Gross Profit (2018 - 2026)

TransMedics has reported Gross Profit for 9 years, with the latest figure at $113.2 million in Q2 2026.

• On a quarterly basis, Gross Profit rose 17.2% year-over-year to $113.2 million in Q2 2026; TTM through Jun 2026 was $392.3 million, a 23.51% increase from a year earlier, with the FY2025 full-year figure at $362.8 million, up 38.43% from the prior year.
• Gross Profit was $113.2 million for Q2 2026 at TransMedics, up from $101.2 million in the prior quarter.
• The five-year high for Gross Profit was $113.2 million in Q2 2026, with the low at $12.1 million in Q1 2022.
• Average Gross Profit over 5 years is $58.8 million, with a median of $60.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Gross Profit soared 380.12% in 2022, then grew 14.66% in 2026.
• Over 5 years, Gross Profit stood at $20.7 million in 2022, then jumped by 131.48% to $47.9 million in 2023, then jumped by 50.27% to $72.0 million in 2024, then climbed by 29.72% to $93.4 million in 2025, then grew by 21.18% to $113.2 million in 2026.
• The last three Gross Profit figures came in at $113.2 million (Q2 2026), $101.2 million (Q1 2026), and $93.4 million (Q4 2025), per Business Quant data.